Search research articles
Contact Us
Filters
Showing results (301-310 of 420) with videos related to
Page
of 42
Sort By:
Diagnostic Microbiology and Infectious Disease
|
March 24, 2009
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens
Ronald N Jones, Jan M Bell, Helio S Sader, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 30, 2019
<i>In Vitro</i> Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (2014-2015) in the United States
Michael A Pfaller, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2020
Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide
Helio S Sader, Leonard R Duncan, S J Ryan Arends, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2016
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
March 26, 2016
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates
Rodrigo E Mendes, Patricia A Hogan, Ronald N Jones, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)
Leonard R Duncan, Helio S Sader, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2014
Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2025
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023)
Helio S Sader, Marisa L Winkler, Krisztina M Papp-Wallace, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 15, 2005
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America
Ana Cristina Gales, Michael A Pfaller, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004)
Thomas R Fritsche, Helio S Sader, Matthew G Stilwell, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 420) with videos related to
Sort By:
Page
of 42
Diagnostic Microbiology and Infectious Disease
|
March 24, 2009
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens
Ronald N Jones, Jan M Bell, Helio S Sader, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 30, 2019
<i>In Vitro</i> Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (2014-2015) in the United States
Michael A Pfaller, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2020
Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide
Helio S Sader, Leonard R Duncan, S J Ryan Arends, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2016
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
March 26, 2016
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates
Rodrigo E Mendes, Patricia A Hogan, Ronald N Jones, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)
Leonard R Duncan, Helio S Sader, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2014
Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2025
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023)
Helio S Sader, Marisa L Winkler, Krisztina M Papp-Wallace, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 15, 2005
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America
Ana Cristina Gales, Michael A Pfaller, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004)
Thomas R Fritsche, Helio S Sader, Matthew G Stilwell, et al.
Page
of 42